CC

Checkpoint Capital Portfolio holdings

AUM $215M
1-Year Return 27.24%
This Quarter Return
+3.78%
1 Year Return
+27.24%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$215M
AUM Growth
+$32.3M
Cap. Flow
+$19.2M
Cap. Flow %
8.94%
Top 10 Hldgs %
100%
Holding
14
New
–
Increased
4
Reduced
4
Closed
6

Top Buys

1
CORT icon
Corcept Therapeutics
CORT
+$24.9M
2
ARGX icon
argenx
ARGX
+$19.3M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$9.65M
4
IRON icon
Disc Medicine
IRON
+$1.15M

Top Sells

1
SLNO icon
Soleno Therapeutics
SLNO
+$12.4M
2
PTGX icon
Protagonist Therapeutics
PTGX
+$5.19M
3
STOK icon
Stoke Therapeutics
STOK
+$4.86M
4
RVMD icon
Revolution Medicines
RVMD
+$4.12M
5
TCRX icon
TScan Therapeutics
TCRX
+$2.78M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARGX icon
1
argenx
ARGX
$46.3B
$82.7M 38.52%
149,977
+34,977
+30% +$19.3M
RYTM icon
2
Rhythm Pharmaceuticals
RYTM
$6.39B
$67M 31.21%
1,060,000
+152,760
+17% +$9.65M
CORT icon
3
Corcept Therapeutics
CORT
$7.68B
$25.2M 11.76%
343,917
+338,917
+6,778% +$24.9M
IRON icon
4
Disc Medicine
IRON
$2.08B
$14M 6.54%
265,000
+21,689
+9% +$1.15M
RVMD icon
5
Revolution Medicines
RVMD
$8.7B
$10.3M 4.8%
280,000
-112,011
-29% -$4.12M
SEPN
6
Septerna, Inc. Common Stock
SEPN
$637M
$6.2M 2.89%
586,473
-238,405
-29% -$2.52M
KYMR icon
7
Kymera Therapeutics
KYMR
$3.36B
$4.67M 2.18%
106,991
-29,614
-22% -$1.29M
PTGX icon
8
Protagonist Therapeutics
PTGX
$3.66B
$4.49M 2.09%
81,311
-93,873
-54% -$5.19M
CDTX icon
9
Cidara Therapeutics
CDTX
$1.66B
– –
-104,380
Closed -$2.25M
IMCR icon
10
Immunocore
IMCR
$1.78B
– –
-9,011
Closed -$267K
RAPT icon
11
RAPT Therapeutics
RAPT
$268M
– –
-13,729
Closed -$134K
SLNO icon
12
Soleno Therapeutics
SLNO
$2.85B
– –
-172,902
Closed -$12.4M
STOK icon
13
Stoke Therapeutics
STOK
$1.29B
– –
-730,717
Closed -$4.86M
TCRX icon
14
TScan Therapeutics
TCRX
$99.9M
– –
-2,017,650
Closed -$2.78M